PRODUCTS
SERVICES
The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
2.39
1 yrs 1 m
1%
307.34 Crs
1% on or before 3M, Nil after 3M
Mid Growth
7.82
SIP 1000 & Lumpsum 500
NA
Nimesh Chandan,Sorbh Gupta,Siddharth Chaudhary
Investors understand that their principal will be at very high risk